T82.837S Hemorrhage due to cardiac prosthetic devices, implants and grafts, sequela

Name of the Condition

Hemorrhage due to cardiac prosthetic devices, implants and grafts, sequela

Summary

This condition represents a late effect (sequela) of bleeding resulting from cardiac prosthetic devices, implants, or grafts. It occurs after the acute phase of the hemorrhage and may involve persistent or recurrent bleeding, tissue damage, or complications related to the device. Clinical evaluation is necessary to assess the residual effects and guide management.

Causes

Sequela of hemorrhage can result from incomplete resolution of the initial bleeding, delayed healing at the implant site, or ongoing issues with device integrity. Underlying factors such as chronic anticoagulation, device erosion, or tissue reaction may contribute to persistent bleeding or related complications.

Risk Factors

• History of prior hemorrhage due to cardiac prosthetic devices
• Chronic use of anticoagulant or antiplatelet therapy
• Impaired wound healing or comorbidities affecting clotting
• Device-related factors (e.g., mechanical failure, erosion)
• Previous surgical revisions or interventions

Symptoms

• Persistent or recurrent bleeding at the implant site
• Chronic pain, swelling, or discoloration around the device
• Signs of anemia or ongoing blood loss (e.g., fatigue, weakness)
• Functional impairment of the device or surrounding tissues

Diagnosis

Diagnosis involves clinical assessment, imaging (e.g., ultrasound, CT), and laboratory tests to evaluate residual bleeding, device status, and tissue damage. Documentation should specify the nature of the sequela and its relationship to the original hemorrhage.

Treatment Options

Management focuses on addressing the underlying cause, such as device repair or replacement, optimizing anticoagulation, or treating anemia. Supportive care may include monitoring for complications and addressing any functional limitations.

Prognosis and Follow-Up

Prognosis depends on the severity of the sequela and response to treatment. Regular follow-up is essential to monitor device function, healing, and potential recurrence of bleeding. Long-term management may involve ongoing imaging or laboratory testing.

Complications

• Chronic anemia or blood loss
• Infection at the implant site
• Device malfunction or failure
• Tissue damage or scarring
• Reduced quality of life due to persistent symptoms

Lifestyle & Prevention

• Adhere to prescribed anticoagulation regimens and monitoring
• Avoid trauma to the implant site
• Report any new or worsening symptoms promptly
• Maintain regular medical follow-up for device evaluation

When to Seek Professional Help

Seek immediate care for signs of active bleeding (e.g., sudden swelling, dizziness, or hypotension) or if symptoms worsen. Contact a healthcare provider for persistent pain, swelling, or unexplained fatigue.

Tips for Medical Coders

Document the relationship between the sequela and the original hemorrhage due to cardiac prosthetic devices. Specify the type of device (e.g., valve, graft) and any contributing factors (e.g., anticoagulation) to support accurate coding. Ensure the sequela is clearly linked to the prior event for proper classification.